187 related articles for article (PubMed ID: 12150138)
21. Lymphomatoid papulosis with folliculotropism, eccrinotropism and neurotropism.
Ba W; Yang Y; Zhang Z; Wei X; Wang W; Zhao Z; Zheng L; Li C
J Cutan Pathol; 2018 Jul; 45(7):530-534. PubMed ID: 29660166
[TBL] [Abstract][Full Text] [Related]
22. [Lymphomatoid papulosis: clinical and pathological findings in 18 patients].
Fernández-Guarino M; Carrillo-Gijón R; Jaén-Olasolo P
Actas Dermosifiliogr; 2012 Jun; 103(5):388-93. PubMed ID: 22261676
[TBL] [Abstract][Full Text] [Related]
23. Follicular lymphomatoid papulosis revisited: a study of 11 cases, with new histopathological findings.
Kempf W; Kazakov DV; Baumgartner HP; Kutzner H
J Am Acad Dermatol; 2013 May; 68(5):809-16. PubMed ID: 23375516
[TBL] [Abstract][Full Text] [Related]
24. IL-4 production by CD8+ lymphomatoid papulosis, type C, attracts background eosinophils.
Slone SP; Martin AW; Wellhausen SR; Woods DR; Malone JC; Lear SC; Laber DA
J Cutan Pathol; 2008 Oct; 35 Suppl 1():38-45. PubMed ID: 18537857
[TBL] [Abstract][Full Text] [Related]
25. Type D lymphomatoid papulosis simulating aggressive epidermotropic cytotoxic lymphoma.
Mani V; George R; Vijayakumar K; Nair S
Indian J Pathol Microbiol; 2016; 59(1):81-3. PubMed ID: 26960644
[TBL] [Abstract][Full Text] [Related]
26. Absence of cytotoxic molecules in CD8- and/or CD56-positive adult T-cell leukaemia/lymphoma.
Ohshima K; Haraoka S; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Kikuchi M
Virchows Arch; 1999 Aug; 435(2):101-4. PubMed ID: 10599307
[TBL] [Abstract][Full Text] [Related]
27. Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-gamma.
Yagi H; Tokura Y; Furukawa F; Takigawa M
J Invest Dermatol; 1996 Dec; 107(6):827-32. PubMed ID: 8941669
[TBL] [Abstract][Full Text] [Related]
28. Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin.
de la Garza Bravo MM; Patel KP; Loghavi S; Curry JL; Torres Cabala CA; Cason RC; Gangar P; Prieto VG; Medeiros LJ; Duvic M; Tetzlaff MT
Hum Pathol; 2015 Apr; 46(4):558-69. PubMed ID: 25666664
[TBL] [Abstract][Full Text] [Related]
29. Expression of T-cell activation marker CD134 (OX40) in lymphomatoid papulosis.
Gniadecki R; Rossen K
Br J Dermatol; 2003 May; 148(5):885-91. PubMed ID: 12786817
[TBL] [Abstract][Full Text] [Related]
30. CD30 antigen expression in cutaneous inflammatory infiltrates of scabies: a dynamic immunophenotypic pattern that should be distinguished from lymphomatoid papulosis.
Gallardo F; Barranco C; Toll A; Pujol RM
J Cutan Pathol; 2002 Jul; 29(6):368-73. PubMed ID: 12135469
[TBL] [Abstract][Full Text] [Related]
31. [Lymphomatoid papulosis in a child].
Léauté-Labrèze C; Bioulac-Sage P; Belleannée G; Merlio JP; Vergnes P; Maleville J; Taïeb A
Arch Pediatr; 1995 Oct; 2(10):984-7. PubMed ID: 7496478
[TBL] [Abstract][Full Text] [Related]
32. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
33. Lymphomatoid papulosis: a clinical and histopathologic review of 53 cases with leukocyte immunophenotyping, DNA flow cytometry, and T-cell receptor gene rearrangement studies.
el-Azhary RA; Gibson LE; Kurtin PJ; Pittelkow MR; Muller SA
J Am Acad Dermatol; 1994 Feb; 30(2 Pt 1):210-8. PubMed ID: 8288780
[TBL] [Abstract][Full Text] [Related]
34. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
35. Lymphomatoid papulosis type D: a newly described variant easily confused with cutaneous aggressive CD8-positive cytotoxic T-cell lymphoma.
Cardoso J; Duhra P; Thway Y; Calonje E
Am J Dermatopathol; 2012 Oct; 34(7):762-5. PubMed ID: 22688398
[TBL] [Abstract][Full Text] [Related]
36. In search of prognostic indicators for lymphomatoid papulosis: a retrospective study of 123 patients.
de Souza A; el-Azhary RA; Camilleri MJ; Wada DA; Appert DL; Gibson LE
J Am Acad Dermatol; 2012 Jun; 66(6):928-37. PubMed ID: 21982062
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases.
Plaza JA; Feldman AL; Magro C
J Cutan Pathol; 2013 Feb; 40(2):236-47. PubMed ID: 23189966
[TBL] [Abstract][Full Text] [Related]
38. Expression of Hodgkin's disease associated antigen BLA.36 in anaplastic large cell lymphomas and lymphomatoid papulosis primarily of T-cell origin.
Cohen PL; Butmarc J; Kadin ME
Am J Clin Pathol; 1995 Jul; 104(1):50-3. PubMed ID: 7611181
[TBL] [Abstract][Full Text] [Related]
39. Oral Lymphomatoid papulosis type C: A diagnostic pitfall, often confused with T-cell lymphoma.
Schwartz Z; Coleman M; Toyohara JP; Freedman PD; Magro CM
Ann Diagn Pathol; 2017 Dec; 31():50-55. PubMed ID: 29146059
[TBL] [Abstract][Full Text] [Related]
40. Resolution of CD8+ lymphomatoid papulosis after surgical excision of the type AB-thymoma.
de Souza A; Gibson LE; Wada DA; Yi ES; Medeiros F; Camilleri MJ; el-Azhary R; Micallef IN
Am J Dermatopathol; 2009 Jul; 31(5):475-9. PubMed ID: 19542925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
